CPMD (Cannapharmarx) Gross Margin %: -65.23% (As of Mar. 2026)


What is Cannapharmarx Gross Margin %?

Cannapharmarx CPMD +4.17% Gross Margin % is -65.23% as of Mar. 2026. The stock has 6 warning signs investors should review. Among 938 Drug Manufacturers companies, Cannapharmarx ranks worse than 99.36% on this metric.

Gross Margin % is calculated as gross profit divided by its revenue. Cannapharmarx's Gross Profit for the three months ended in Mar. 2026 was $-0.41 Mil. Cannapharmarx's Revenue for the three months ended in Mar. 2026 was $0.63 Mil. Therefore, Cannapharmarx's Gross Margin % for the quarter that ended in Mar. 2026 was -65.23%.


The historical rank and industry rank for Cannapharmarx's Gross Margin % or its related term are showing as below:

CPMD' s Gross Margin % Range Over the Past 10 Years
Min: -357.93   Med: -255.51   Max: -120.3
Current: -120.3


During the past 13 years, the highest Gross Margin % of Cannapharmarx was -120.30%. The lowest was -357.93%. And the median was -255.51%.

CPMD's Gross Margin % is ranked worse than
99.36% of 938 companies
in the Drug Manufacturers industry
Industry Median: 48.44 vs CPMD: -120.30

Cannapharmarx had a gross margin of -65.23% for the quarter that ended in Mar. 2026 => No sustainable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Cannapharmarx was 0.00% per year.


Cannapharmarx  (OTCPK:CPMD) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Cannapharmarx had a gross margin of -65.23% for the quarter that ended in Mar. 2026 => No sustainable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Cannapharmarx Gross Margin % Related Terms


Cannapharmarx Gross Margin % Historical Data

* Premium members only.

The historical data trend for Cannapharmarx's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cannapharmarx Gross Margin % Chart

Cannapharmarx Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 -357.93 -153.08

Cannapharmarx Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -150.15 -267.67 -66.97 -374.82 -65.23

CPMD vs IMCC, SKYI, BSPK: Gross Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Cannapharmarx's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cannapharmarx Gross Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cannapharmarx's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Cannapharmarx's Gross Margin % falls into.



Cannapharmarx Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Cannapharmarx's Gross Margin for the fiscal year that ended in Dec. 2025 is calculated as

Gross Margin % (A: Dec. 2025 )=Gross Profit (A: Dec. 2025 ) / Revenue (A: Dec. 2025 )
=-2.1 / 1.362
=(Revenue - Cost of Goods Sold) / Revenue
=(1.362 - 3.447) / 1.362
=-153.08 %

Cannapharmarx's Gross Margin for the quarter that ended in Mar. 2026 is calculated as


Gross Margin % (Q: Mar. 2026 )=Gross Profit (Q: Mar. 2026 ) / Revenue (Q: Mar. 2026 )
=-0.4 / 0.627
=(Revenue - Cost of Goods Sold) / Revenue
=(0.627 - 1.036) / 0.627
=-65.23 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Frequently Asked Questions Learn more about Gross Margin % →
What does a Gross Margin % of -65.23% mean?
Cannapharmarx (CPMD) has a Gross Margin % of -65.23% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Cannapharmarx and its competitors. According to the industry distribution chart, Cannapharmarx ranks #932 out of 938 companies in the Drug Manufacturers industry, placing it in the top 99.4%.
Is Cannapharmarx's Gross Margin % too high?
Cannapharmarx's current Gross Margin % is -65.23%. Based on the distribution chart, Cannapharmarx ranks #932 out of 938 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does Cannapharmarx's Gross Margin % compare to IMCC and SKYI?
According to the Drug Manufacturers industry distribution chart, Cannapharmarx ranks #932 out of 938 companies for Gross Margin %. This places Cannapharmarx in the lower half of its industry. The industry median Gross Margin % is 48.44. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Drug Manufacturers company?
The median Gross Margin % among Drug Manufacturers companies is 48.44, based on 938 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Cannapharmarx and its competitors. For the Drug Manufacturers industry, the median Gross Margin % is 48.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cannapharmarx's current Gross Margin % is -65.23%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cannapharmarx stock overvalued right now?
Cannapharmarx (CPMD) has a current Gross Margin % of -65.23%. The current Gross Margin % is -65.23%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Cannapharmarx (CPMD), the current Gross Margin % is -65.23% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cannapharmarx Business Description

Address 4439 Township Road 304, Suite 302, Mountain View County, Central Alberta, AB, CAN, T0M 0R0
Cannapharmarx Inc specializes in the acquisition, development, and operation of cannabis cultivation facilities in Canada. The group evolved to focus on producing medical cannabis and craft products. The products of the company are Unique Genetics, Craft Products, and Medical Cannabis.